These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 135003)

  • 21. Prenatal diagnosis in 3,000 women for chromosome, X-linked, and metabolic disorders.
    Daniel A; Stewart L; Saville T; Brookwell R; Paull H; Purvis-Smith S; Lam-Po-Tang PR
    Am J Med Genet; 1982 Jan; 11(1):61-75. PubMed ID: 7065004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-natal counselling and diagnosis in Down's syndrome.
    Papp Z
    Med Gynaecol Androl Sociol; 1973; 7(4):10-5. PubMed ID: 12156379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Karyotyping of fetal cells in the prenatal diagnosis in Costa Rica].
    Castro Volio I; Escalante López G; Mora Palma H; Guerra Carles D; Sánchez Chaves L; Peña Obando C
    Rev Biol Trop; 1995; 43(1-3):31-7. PubMed ID: 8728757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gynecological aspects of prenatal diagnosis of congenital anomalies (author's transl)].
    Knörr K; Jonatha WD; Tettenborn U
    MMW Munch Med Wochenschr; 1976 May; 118(19):589-94. PubMed ID: 132608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical approach to prenatal diagnosis of chromosome abnormalities].
    Herlicoviez M
    Reprod Nutr Dev; 1990; Suppl 1():139s-145s. PubMed ID: 2206291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multiple chromosome aberrations in 3 generations of a family and Down's syndrome resulting from partial trisomy of chromosome 21 (q21--q22)].
    Butomo IV; Prozorova MV; Khitrikova LE
    Tsitol Genet; 1984; 18(3):223-8. PubMed ID: 6235655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal diagnosis in France.
    Aymé S; Morichon N; Goujard J; Nisand I
    Eur J Hum Genet; 1997; 5 Suppl 1():26-31. PubMed ID: 9101175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prenatal diagnosis in pregnancies at advanced maternal age (author's transl)].
    Wirtz A; Haas B; Krauss C; Stengel-Rutkowski S; Murken JD
    Geburtshilfe Frauenheilkd; 1978 Jun; 38(6):422-30. PubMed ID: 149691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Structural chromosomal reorganizations and mosaicism in the parents of children with Down's syndrome].
    Butomo IV; Kovaleva NV
    Tsitol Genet; 1993; 27(1):87-91. PubMed ID: 8316960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytogenetic results of amniocentesis materials: incidence of abnormal karyotypes in the Turkish collaborative study.
    Karaoguz MY; Bal F; Yakut T; Ercelen NO; Ergun MA; Gokcen AB; Biri AA; Kimya Y; Urman B; Gultomruk M; Egeli U; Menevse S
    Genet Couns; 2006; 17(2):219-30. PubMed ID: 16970041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal serum alpha-fetoprotein screening and fetal chromosome anomalies: is lowering maternal age for amniocentesis preferable?
    Kaffe S; Hsu LY
    Am J Med Genet; 1992 Apr; 42(6):801-6. PubMed ID: 1372793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Investigation of the incidence of aberration in various indication for prenatal cytogenetic analysis].
    Matsuo T; Hisanaga S; Maeda H; Tukimori K; Matsuo K; Nagata H; Nakano H
    Fukuoka Igaku Zasshi; 1992 Oct; 83(10):377-82. PubMed ID: 1464405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosome 21 behavior during fetal oogenesis in Down's syndrome.
    Jagiello GM; Fang JS; Nogawa T; Sung WK; Ducayen MB; Bowne W
    Obstet Gynecol; 1987 Dec; 70(6):878-83. PubMed ID: 2960924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [First experiences with amniocentesis from genetic indications].
    Kunz J; Schmid J; Schmid W; Schreiner WE
    Schweiz Med Wochenschr; 1975 Nov; 105(46):1525-32. PubMed ID: 56777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prenatal diagnosis of fetal malformations from the obstetrician's viewpoint].
    Winter R
    Wien Klin Wochenschr; 1983 Feb; 95(3):67-78. PubMed ID: 6190319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Incidence of fetal chromosomal aberration in prenatal cytogenetic examination].
    Uehara S; Takabayashi T; Miyashita N; Kosuge S; Murotsuki J; Kurahayashi Y; Kimura H; Iwamoto M; Endo H; Watanabe T
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1333-40. PubMed ID: 1955786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of first-trimester chromosome, DNA, and metabolic studies on pregnancies at high genetic risk: experience with 1,000 cases.
    Sachs ES; Jahoda MG; Kleijer WJ; Pijpers L; Galjaard H
    Am J Med Genet; 1988 Feb; 29(2):293-303. PubMed ID: 3354601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.